BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11302919)

  • 1. Atypical antipsychotics in the treatment of schizophrenia. Users' views are important.
    Anderson I
    BMJ; 2001 Apr; 322(7291):926; author reply 927-8. PubMed ID: 11302919
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antipsychotics in the treatment of schizophrenia. Paper underrates patients' experience of extrapyramidal symptoms.
    Kerwin R
    BMJ; 2001 Apr; 322(7291):926-7; author reply 927-8. PubMed ID: 11302914
    [No Abstract]   [Full Text] [Related]  

  • 3. Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients.
    Høiberg MP; Nielsen B
    Nord J Psychiatry; 2006; 60(3):207-12. PubMed ID: 16720511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Schizophrenia: adverse effects of atypical neuroleptics].
    Bettina Polk B
    Med Monatsschr Pharm; 2003 Feb; 26(2):57-9. PubMed ID: 12619525
    [No Abstract]   [Full Text] [Related]  

  • 6. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
    Leucht S; Kissling W; Davis JM
    Psychol Med; 2009 Oct; 39(10):1591-602. PubMed ID: 19335931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching in the era of atypical antipsychotics. An updated review.
    Weiden PJ
    Postgrad Med; 2006 Sep; Spec No():27-44. PubMed ID: 17128659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From neuroleptics toward antipsychotics: practice of changing the treatment, choice of the time and disputes, clinical aspects].
    Plas J
    Encephale; 2003 Sep; 29(Pt 2):S40-2. PubMed ID: 14710536
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
    Nasrallah HA; Tandon R
    J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First- and second-generation antipsychotics: learning from CUtLASS and CATIE.
    Tandon R; Carpenter WT; Davis JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):977-8; author reply 979-80. PubMed ID: 17679642
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of antipsychotics on brain structure.
    Scherk H; Falkai P
    Curr Opin Psychiatry; 2006 Mar; 19(2):145-50. PubMed ID: 16612194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing an atypical antipsychotic.
    Sussman N
    Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S29-33. PubMed ID: 12570069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unwanted effects of psychotrophic drugs. II.--Drugs for schizophrenia.
    Edwards JG
    Practitioner; 1977 May; 218(1307):696-700. PubMed ID: 18729
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of schizophrenia].
    Houy-Durand E; Thibaut F
    Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of schizophrenia.
    Bennett DH
    Br J Psychiatry; 1975; Spec No 9():48-54. PubMed ID: 241452
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics.
    Strejilevich SA; Palatnik A; Avila R; Bustin J; Cassone J; Figueroa S; Gimenez M; de Erausquin GA
    Psychiatry Res; 2005 Feb; 133(2-3):277-80. PubMed ID: 15741003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic drugs--an update.
    Charalampous KD; Keepers GA
    J Okla State Med Assoc; 1978 Jan; 71(1):6-9. PubMed ID: 23420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.